Ross Chambers

VP, Antibody Discovery at Integral Molecular

Ross directs all antibody discovery projects at Integral Molecular. He pioneered the use of DNA immunization for antibody discovery and developed the Picodroplet cloning system for isolating antibodies directly from B cells. Ross has led over 100 therapeutic MAb discovery campaigns at Integral Molecular that successfully identified MAb candidates for GPCRs, ion channels, and transporters.

Ross brings over 20 years of experience in antibody discovery in academia and industry, including projects involving high-throughput discovery of antibodies for challenging targets. Previously, he was the Director of Research and Development at SDIX where he invented and developed the Genomic Antibody Technology (GAT) for rapid antibody isolation. Prior to that, he isolated > 2,000 antibodies as part of a large-scale antibody isolation project at UT Southwestern. Ross received his Ph.D. in Biochemistry and B.S. from the University of Otago, New Zealand, and completed post-docs at UC Davis and Berkeley.

Location

Philadelphia, United States

Links


Org chart

No direct reports

Teams


Offices


Integral Molecular

Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies


Industries

Employees

51-200

Links